Journal of Nobel Medical College (Dec 2021)

Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

  • Sushmita Khanal,
  • Sunil Babu Khanal

DOI
https://doi.org/10.3126/jonmc.v10i2.41790
Journal volume & issue
Vol. 10, no. 2
pp. 63 – 64

Abstract

Read online

Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.

Keywords